About the ABPI

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

  • The Heads of Agreement have been agreed for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access . Negotiations will continue towards a full agreement which is expected to be published in due course.
  • If agreed in full, the 2019 Voluntary Scheme for Branded Medicines Pricing and Access will replace the Pharmaceutical Pricing Regulation Scheme (PPRS), which expires on 31 December 2018.

Media enquiries


+44 (0) 20 7747 7147​​